Biofrontera Inc. (BFRI) vs Pluri Inc. (PLUR)

A side-by-side comparison of Biofrontera Inc. and Pluri Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Biofrontera Inc. logo
BFRI
Biofrontera Inc.
$12M
$0.93HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Pluri Inc. logo
PLUR
Pluri Inc.
$11M
$0.99HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BFRI vs PLUR

growth of $100 · dividends reinvested · last 5y
BFRI -99.0% (-60.1%/yr)PLUR -95.3% (-45.8%/yr)PLUR compounded faster over this window
0100200300Start $10020222023202420252026$1$5
BFRI PLUR

BFRI vs PLUR: by the numbers

  • •BFRI is the larger company ($12M vs $11M market cap).
  • •Both run net losses; BFRI's is the smaller (-13.78% vs -2406.00% net margin).

Metrics side by side

Valuation

MetricBFRIPLUR
P/S ratio0.2610.51
P/B ratio2.00N/A

Profitability

MetricBFRIPLUR
Gross margin84.45%44.59%
Operating margin-21.94%-2455.91%
Net margin-13.78%-2406.00%
ROE-106.87%N/A
ROIC-32.27%-127.37%

Growth (annualized)

MetricBFRIPLUR
Revenue CAGR (5Y)15.55%N/A
Total return CAGR (5Y)N/A-44.78%

Go deeper

Full BFRI analysisFull PLUR analysisInteractive comparison tool

Dig into the metrics

Biofrontera ROEPluri ROEBiofrontera operating marginPluri operating marginBiofrontera revenue growthPluri revenue growthBiofrontera free cash flowPluri free cash flow

Biofrontera & Pluri appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.